Pharmacokinetics of nevirapine: initial single-rising-dose study in humans.
Nevirapine, a nonnucleoside inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase, was administered for the first time to humans in a pilot study designed to investigate the pharmacokinetics and tolerance of the drug following single-dose administration to 21 HIV-1-infected...
Zapisane w:
| Wydane w: | Antimicrob Agents Chemother |
|---|---|
| Główni autorzy: | , , , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
American Society for Microbiology (ASM)
1993
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC187634/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8452345/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.37.2.178 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|